| pubmed-article:1899879 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1899879 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1899879 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:1899879 | lifeskim:mentions | umls-concept:C0241888 | lld:lifeskim |
| pubmed-article:1899879 | lifeskim:mentions | umls-concept:C0152025 | lld:lifeskim |
| pubmed-article:1899879 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
| pubmed-article:1899879 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1899879 | pubmed:dateCreated | 1991-3-22 | lld:pubmed |
| pubmed-article:1899879 | pubmed:abstractText | This study was performed to evaluate hypothalamic-pituitary hormone regulation in patients with familial amyloidotic polyneuropathy. Twenty-two patients without clinically overt endocrinological dysfunction were studied. A thyrotropin-releasing hormone test revealed abnormal growth hormone regulation in 9 of 17 (53%) patients, and abnormal prolactin regulation in 9 of 18 (50%) patients. Abnormalities in either growth hormone or prolactin regulation were found in 12 of 17 (71%) patients. Serum somatomedin C levels were normal in all 22 patients. In 3 of 18 (17%) patients the plasma arginine vasopressin levels were low relative to the serum osmolality levels. Thus abnormalities in hypothalamic-pituitary hormone regulation may be common in familial amyloidotic polyneuropathy. | lld:pubmed |
| pubmed-article:1899879 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1899879 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1899879 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1899879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1899879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1899879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1899879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1899879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1899879 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1899879 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:1899879 | pubmed:issn | 0954-6820 | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:LithnerFF | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:GrankvistKK | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:OlssonTT | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:ForsbergKK | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:BomanKK | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:LafvasII | lld:pubmed |
| pubmed-article:1899879 | pubmed:author | pubmed-author:OlofssonB OBO | lld:pubmed |
| pubmed-article:1899879 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1899879 | pubmed:volume | 229 | lld:pubmed |
| pubmed-article:1899879 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1899879 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1899879 | pubmed:pagination | 55-9 | lld:pubmed |
| pubmed-article:1899879 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:meshHeading | pubmed-meshheading:1899879-... | lld:pubmed |
| pubmed-article:1899879 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1899879 | pubmed:articleTitle | Assessment of hypothalamic-pituitary function in patients with familial amyloidotic polyneuropathy. | lld:pubmed |
| pubmed-article:1899879 | pubmed:affiliation | Department of Internal Medicine, Chemistry, University of Umeå, Sweden. | lld:pubmed |
| pubmed-article:1899879 | pubmed:publicationType | Journal Article | lld:pubmed |
